Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 26050 | 264 | 30.2 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
| 85 | 2 | ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN | 27105 |
| 26050 | 1 | UNITE PHYSIOL INTEGREE//PITHED SHR//PREJUNCTIONAL INTERACTION | 264 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | UNITE PHYSIOL INTEGREE | address | 378531 | 2% | 55% | 6 |
| 2 | PITHED SHR | authKW | 231328 | 1% | 100% | 2 |
| 3 | PREJUNCTIONAL INTERACTION | authKW | 231328 | 1% | 100% | 2 |
| 4 | PRESYNAPTIC ANGIOTENSIN RECEPTORS | authKW | 231328 | 1% | 100% | 2 |
| 5 | ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST | authKW | 222425 | 2% | 38% | 5 |
| 6 | PATHOL VASC | address | 166547 | 2% | 24% | 6 |
| 7 | VASCULAR ALPHA 1 ADRENOCEPTORS | authKW | 154217 | 1% | 67% | 2 |
| 8 | ALPHA 1 ADRENOCEPTOR VASCULAR | authKW | 115664 | 0% | 100% | 1 |
| 9 | ALPHA1 ANGIOTENSIN II INTERACTION | authKW | 115664 | 0% | 100% | 1 |
| 10 | AND NEUROHUMORAL CONTROL OF THE CIRCULATION | authKW | 115664 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 2306 | 28% | 0% | 73 |
| 2 | Pharmacology & Pharmacy | 1788 | 48% | 0% | 127 |
| 3 | Cardiac & Cardiovascular System | 858 | 23% | 0% | 61 |
| 4 | Physiology | 491 | 16% | 0% | 41 |
| 5 | Medicine, Research & Experimental | 32 | 5% | 0% | 14 |
| 6 | Medical Laboratory Technology | 2 | 1% | 0% | 2 |
| 7 | Neurosciences | 1 | 4% | 0% | 11 |
| 8 | Hematology | 0 | 1% | 0% | 3 |
| 9 | Urology & Nephrology | -0 | 1% | 0% | 2 |
| 10 | Biophysics | -0 | 1% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | UNITE PHYSIOL INTEGREE | 378531 | 2% | 55% | 6 |
| 2 | PATHOL VASC | 166547 | 2% | 24% | 6 |
| 3 | EXPT CLIN PHARM TOXICOL | 115664 | 0% | 100% | 1 |
| 4 | INSERM ERI AG S VASC REPONSES TISSULAI 22 | 115664 | 0% | 100% | 1 |
| 5 | PHARMACOL GRP BIOMED HLTH SCI | 115664 | 0% | 100% | 1 |
| 6 | ROCKEFELLERERI 22 | 115664 | 0% | 100% | 1 |
| 7 | SN FEDEROVO EYE MICROSURG STATE SCI TECHNOL COM | 115664 | 0% | 100% | 1 |
| 8 | UNIDAD INVEST FARMACOL TOXICOL | 115664 | 0% | 100% | 1 |
| 9 | INSERM ERI 22 | 66091 | 1% | 29% | 2 |
| 10 | ROCKFELLER | 57831 | 0% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF HYPERTENSION | 6327 | 9% | 0% | 23 |
| 2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 5081 | 8% | 0% | 22 |
| 3 | CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2999 | 5% | 0% | 12 |
| 4 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2738 | 5% | 0% | 12 |
| 5 | HYPERTENSION | 2253 | 6% | 0% | 15 |
| 6 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 2104 | 2% | 0% | 5 |
| 7 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 2100 | 2% | 0% | 4 |
| 8 | ASIA PACIFIC JOURNAL OF PHARMACOLOGY | 1631 | 1% | 1% | 2 |
| 9 | BRITISH JOURNAL OF PHARMACOLOGY | 1452 | 6% | 0% | 15 |
| 10 | JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM | 1229 | 2% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BALT, JC , MATHY, MJ , PFAFFENDORF, M , VAN ZWIETEN, PA , (2001) INHIBITION OF ANGIOTENSIN II-INDUCED FACILITATION OF SYMPATHETIC NEUROTRANSMISSION IN THE PITHED RAT: A COMPARISON BETWEEN LOSARTAN, IRBESARTAN, TELMISARTAN AND CAPTOPRIL.JOURNAL OF HYPERTENSION. VOL. 19. ISSUE 3. P. 465 -473 | 19 | 68% | 22 |
| 2 | DENDORFER, A , RAASCH, W , TEMPEL, K , DOMINIAK, P , (2002) COMPARISON OF THE VASCULAR AND ANTIADRENERGIC ACTIVITIES OF FOUR ANGIOTENSIN II TYPE 1 ANTAGONISTS IN THE PITHED RAT.JOURNAL OF HYPERTENSION. VOL. 20. ISSUE 6. P. 1151-1156 | 18 | 62% | 16 |
| 3 | BALT, JC , MATHY, MJ , PFAFFENDORF, M , VAN ZWIETEN, PA , (2001) INHIBITION OF FACILITATION OF SYMPATHETIC NEUROTRANSMISSION AND ANGIOTENSIN II-INDUCED PRESSOR EFFECTS IN THE PITHED RAT: COMPARISON BETWEEN VALSARTAN, CANDESARTAN, EPROSARTAN AND EMBUSARTAN.JOURNAL OF HYPERTENSION. VOL. 19. ISSUE 12. P. 2241-2250 | 19 | 58% | 29 |
| 4 | NAP, A , BALT, JC , PFAFFENDORF, M , VAN ZWIETEN, PA , (2002) SYMPATHOLYTIC PROPERTIES OF SEVERAL AT(1)-RECEPTOR ANTAGONISTS IN THE ISOLATED RABBIT THORACIC AORTA.JOURNAL OF HYPERTENSION. VOL. 20. ISSUE 9. P. 1821-1828 | 20 | 54% | 9 |
| 5 | GUIMARAES, S , CARNEIRO, C , BRANDAO, F , PINHEIRO, H , ALBINO-TEIXEIRA, A , MOURA, D , (2004) A PHARMACOLOGICAL DIFFERENTIATION BETWEEN POSTJUNCTIONAL (AT(1A)) AND PREJUNCTIONAL (AT(1B)) ANGIOTENSIN II RECEPTORS IN THE RABBIT AORTA.NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. VOL. 370. ISSUE 4. P. 262-269 | 15 | 63% | 3 |
| 6 | DENDORFER, A , DOMINIAK, P , TEMPEL, K , RAASCH, W , (2005) PERIPHERAL SYMPATHOLYTIC ACTIONS OF FOUR AT(1) ANTAGONISTS: ARE THEY RELEVANT FOR-LONG-TERM ANTIHYPERTENSIVE EFFICACY?.JOURNAL OF HYPERTENSION. VOL. 23. ISSUE 10. P. 1861-1867 | 17 | 45% | 7 |
| 7 | BALT, JC , MATHY, MJ , NAP, A , PFAFFENDORF, M , VAN ZWIETEN, PA , (2002) PREJUNCTIONAL AND POSTJUNCTIONAL INHIBITORY ACTIONS OF EPROSARTAN AND CANDESARTAN IN THE ISOLATED RABBIT MESENTERIC ARTERY.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 40. ISSUE 1. P. 50-57 | 16 | 52% | 10 |
| 8 | NAP, A , BALT, JC , MATHY, MJ , PFAFFENDORF, M , VAN ZWIETEN, PA , (2004) DIFFERENT AT(1) RECEPTOR SUBTYPES AT PRE- AND POSTJUNCTIONAL SITES: AT(1A) VERSUS AT(1B) RECEPTORS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 43. ISSUE 1. P. 14-20 | 15 | 50% | 5 |
| 9 | NAP, A , PFAFFENDORF, M , VAN ZWIETEN, PA , (2001) CHARACTERISATION OF A MODIFIED APPROACH TO THE STUDY OF SYMPATHETIC NEUROTRANSMISSION AND ITS PRESYNAPTIC MODULATION IN THE ISOLATED RABBIT THORACIC AORTA.JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. VOL. 46. ISSUE 3. P. 145-151 | 12 | 67% | 1 |
| 10 | BALT, JC , MATHY, MJ , NAP, A , PFAFFENDORF, M , VAN ZWIETEN, PA , (2001) EFFECT OF THE AT(1)-RECEPTOR ANTAGONISTS LOSARTAN, IRBESARTAN, AND TELMISARTAN ON ANGIOTENSIN II-INDUCED FACILITATION OF SYMPATHETIC NEUROTRANSMISSION IN THE RAT MESENTERIC ARTERY.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 38. ISSUE 1. P. 141-148 | 16 | 47% | 30 |
Classes with closest relation at Level 1 |